Literature DB >> 30451017

A characterization and disproportionality analysis of medication error related adverse events reported to the FAERS database.

Carla Carnovale1, Faizan Mazhar1, Marco Pozzi2, Marta Gentili1, Emilio Clementi1,2, Sonia Radice1.   

Abstract

OBJECTIVES: To characterize adverse reactions associated with medication errors (ME) reported in US Food and Drug Administration Adverse Event Reporting System (US-FAERS), and to identify the potential signals of disproportionate reporting (SDR) for different drugs.
METHODS: ME associated Individual Case Study Report (ICSRs) were identified. ICSRs were categorized by patient age groups, affected stages of medication process and Anatomical Therapeutic Chemical classification system. Disproportionality analyses were performed for different age groups.
RESULTS: 46,8677 ICSRs were retrieved. An increasing trend in reporting of cases of ME was observed during the studied period. Immunosuppressants and psycholeptic drugs were most frequently involved. Administration errors were reported most frequently, followed by prescribing and dispensing errors. In neonates, SDR following wrong drug administration, wrong dose, and accidental overdose were associated with methylergonovine, zidovudine, and acetaminophen. In elderlies, SDR were found for dose omission and underdose error associated with etanercept and evolocumab.
CONCLUSION: While a detailed root-cause analysis for ME characteristic can rarely be performed on such a dataset, data mining for signals in spontaneous reporting database may assist in identifying potential ME in a more standardized and objective manner. Continued use of spontaneous reporting system for identifying MEs is encouraged to prevent unnecessary patient harm.

Entities:  

Keywords:  Medication error; adverse events; patient safety; signal detection

Mesh:

Year:  2018        PMID: 30451017     DOI: 10.1080/14740338.2018.1550069

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  9 in total

1.  Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance-Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.

Authors:  Faizan Mazhar; Marco Pozzi; Marta Gentili; Marco Scatigna; Emilio Clementi; Sonia Radice; Carla Carnovale
Journal:  CNS Drugs       Date:  2019-06       Impact factor: 5.749

2.  Methodological approaches for medication error analyses in patient safety and pharmacovigilance reporting systems: a scoping review protocol.

Authors:  Olga Tchijevitch; Sebrina Maj-Britt Hansen; Søren Bie Bogh; Jesper Hallas; Søren Birkeland
Journal:  BMJ Open       Date:  2022-05-24       Impact factor: 3.006

3.  Antibiotic-Induced Neutropenia in Pediatric Patients: New Insights From Pharmacoepidemiological Analyses and a Systematic Review.

Authors:  Vera Battini; Alessandra Mari; Michele Gringeri; Francesca Casini; Francesco Bergamaschi; Giulia Mosini; Greta Guarnieri; Marco Pozzi; Maria Nobile; Gianvincenzo Zuccotti; Emilio Clementi; Sonia Radice; Valentina Fabiano; Carla Carnovale
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

4.  Increased acid sphingomyelinase levels in pediatric patients with obesity.

Authors:  Chiara Mameli; Carla Carnovale; Federico Ambrogi; Gabriele Infante; Paulina Roux Biejat; Alessandra Napoli; Marco Coazzoli; Valeria Calcaterra; Laura Schneider; Chiara Perazzi; Gianvincenzo Zuccotti; Emilio Clementi; Claudia Moscheni; Cristiana Perrotta
Journal:  Sci Rep       Date:  2022-06-29       Impact factor: 4.996

5.  Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System.

Authors:  Haoning Guo; Bin Wang; Shuying Yuan; Silin Wu; Jing Liu; Miaoquan He; Jisheng Wang
Journal:  Front Pharmacol       Date:  2022-04-08       Impact factor: 5.988

6.  Risk factors associated with unintentional medication discrepancies at admission in an internal medicine department.

Authors:  Morgane Masse; Cécile Yelnik; Julien Labreuche; Loïc André; Edgar Bakhache; Bertrand Décaudin; Elodie Drumez; Pascal Odou; Mathilde Dambrine; Marc Lambert
Journal:  Intern Emerg Med       Date:  2021-06-20       Impact factor: 3.397

7.  Appropriateness of care: from medication reconciliation to deprescribing.

Authors:  Maddalena Alessandra Wu; Carla Carnovale; Claudia Gabiati; Daniela Montori; Antonio Brucato
Journal:  Intern Emerg Med       Date:  2021-09-28       Impact factor: 3.397

8.  Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data.

Authors:  Nils Kuklik; Jürgen Stausberg; Marjan Amiri; Karl-Heinz Jöckel
Journal:  BMC Health Serv Res       Date:  2019-08-08       Impact factor: 2.655

Review 9.  Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review.

Authors:  Carla Carnovale; Vera Battini; Michele Gringeri; Marina Volonté; Maria Chiara Uboldi; Andrea Chiarenza; Giovanni Passalacqua
Journal:  World Allergy Organ J       Date:  2022-07-02       Impact factor: 5.516

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.